113 related articles for article (PubMed ID: 19954047)
21. Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial.
Kuo CH; Hu HM; Kuo FC; Hsu PI; Chen A; Yu FJ; Tsai PY; Wu IC; Wang SW; Li CJ; Weng BC; Chang LL; Jan CM; Wang WM; Wu DC
J Antimicrob Chemother; 2009 May; 63(5):1017-24. PubMed ID: 19246508
[TBL] [Abstract][Full Text] [Related]
22. [Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections].
Trinchieri A; Marchetti F
Arch Ital Urol Androl; 2003 Mar; 75(1):49-52. PubMed ID: 12741347
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
Murray JJ; Emparanza P; Lesinskas E; Tawadrous M; Breen JD
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):194-200. PubMed ID: 16087013
[TBL] [Abstract][Full Text] [Related]
24. [Multicenter evaluation on the efficacy and safety of sparfloxacin in the treatment of acute bacterial infections].
Cai Y; Liang D; Xu N; Miao J; Qiu D; Wen C
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):291-3, 325. PubMed ID: 12575213
[TBL] [Abstract][Full Text] [Related]
25. A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections.
Zhao C; Li J; Hou J; Guo M; Zhang Y; Chen Y
Chin Med J (Engl); 2000 Nov; 113(11):1026-30. PubMed ID: 11776118
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and pharmacodynamics of levofloxacin in critically ill patients with ventilator-associated pneumonia.
Benko R; Matuz M; Doro P; Peto Z; Molnar A; Hajdu E; Nagy E; Gardi J; Soos G
Int J Antimicrob Agents; 2007 Aug; 30(2):162-8. PubMed ID: 17570646
[TBL] [Abstract][Full Text] [Related]
27. [A randomized controlled clinical study of sparfloxacin versus ofloxacin in the treatment of bacterial infections].
Hu P; Zou Q; Jiang Y; Wang Q; Jiang S; Hu D; Zhu L; Li S
Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):22-6. PubMed ID: 11798621
[TBL] [Abstract][Full Text] [Related]
28. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
[TBL] [Abstract][Full Text] [Related]
29. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen.
Tribble DR; Sanders JW; Pang LW; Mason C; Pitarangsi C; Baqar S; Armstrong A; Hshieh P; Fox A; Maley EA; Lebron C; Faix DJ; Lawler JV; Nayak G; Lewis M; Bodhidatta L; Scott DA
Clin Infect Dis; 2007 Feb; 44(3):338-46. PubMed ID: 17205438
[TBL] [Abstract][Full Text] [Related]
30. [Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications].
Gehanno P; Pessey JJ; Serrano E
Med Mal Infect; 2005 Jun; 35(6):335-43. PubMed ID: 16023320
[TBL] [Abstract][Full Text] [Related]
31. [Use of levofloxacin in the hospital].
Castells X; Vallano A; Campany D; Rigau D; Arnau JM
Rev Esp Quimioter; 2003 Jun; 16(2):221-6. PubMed ID: 12973461
[TBL] [Abstract][Full Text] [Related]
32. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.
Di Caro S; Franceschi F; Mariani A; Thompson F; Raimondo D; Masci E; Testoni A; La Rocca E; Gasbarrini A
Dig Liver Dis; 2009 Jul; 41(7):480-5. PubMed ID: 18974025
[TBL] [Abstract][Full Text] [Related]
33. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders.
Noel GJ; Bradley JS; Kauffman RE; Duffy CM; Gerbino PG; Arguedas A; Bagchi P; Balis DA; Blumer JL
Pediatr Infect Dis J; 2007 Oct; 26(10):879-91. PubMed ID: 17901792
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
Paglia M; Peterson J; Fisher AC; Qin Z; Nicholson SC; Kahn JB
Curr Med Res Opin; 2010 Jun; 26(6):1433-41. PubMed ID: 20394471
[TBL] [Abstract][Full Text] [Related]
35. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
Urueta-Robledo J; Ariza H; Jardim JR; Caballero A; García-Calderón A; Amábile-Cuevas CF; Hernández-Oliva G; Vivar-Orozco R;
Respir Med; 2006 Sep; 100(9):1504-11. PubMed ID: 16504492
[TBL] [Abstract][Full Text] [Related]
36. [Practice management of chronic bacterial prostatitis with levofloxacin].
Wagenlehner F; Roscher K; Naber KG
Aktuelle Urol; 2011 May; 42(3):184-9. PubMed ID: 21445824
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of the effectiveness of levofloxacin and cefuroxime for the treatment of sinusitis].
Li XP; Qin ZM; Zheng RH; Tan QL; Zhou YY; Zhu L; Yin AF
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Dec; 14(12):573-5. PubMed ID: 12563960
[TBL] [Abstract][Full Text] [Related]
39. [Etiotropic therapy of chronic bacterial prostatitis].
Popov SV; Mazo EB
Urologiia; 2008; (3):36, 38-41. PubMed ID: 18669346
[TBL] [Abstract][Full Text] [Related]
40. [Adverse drug reaction and rational use of levofloxacin: a prospective study].
Zhang Z; Zhen J; Zhan S
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Dec; 22(6):405-7. PubMed ID: 11851050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
